Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
In plain words An early phase 1 study of oregano in people 18 to 64, run by Washington State University. It plans to enroll about 16 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 64; healthy volunteers accepted. Conditions: Interaction.
- Between 18-64 years old and healthy
- Not taking any medications (prescription and non-prescription) or dietary/herbal supplements that can interfere with study drug pharmacokinetics
- Willing to abstain from consuming dietary/herbal supplements and citrus juices for several weeks
- Willing to abstain from cannabis/marijuana, hemp, and THC- and CBD-containing products for several weeks
5 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Oregano; Drug cocktail
Registered summary
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Where, as registered
1 US site in 1 state.